Goodwin

Tevia Pollard

Deals
4
Latest
Aug 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 4 deals
Deals by year
Tevia Pollard: deals by year0123420252026 YTD: 3 M&A2026 YTD: 1 Equity raisings42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Tevia Pollard was named on, most recent first
Aug 2026 Slate Medicines –Fulcrum TherapeuticsMergerLegal adviser to Fulcrum TherapeuticsAnnounced–Biotech+1Fulcrum Therapeutics and Slate Medicines merger
Apr 2026 Robocath –StereotaxisAcquisitionLegal adviser to Robocath (target)Announced–Medtech+1Stereotaxis acquisition of Robocath
Apr 2026 Obsidian Therapeutics ––PlacementLegal adviser to Obsidian TherapeuticsCompleted350.0Biotech+2Obsidian Therapeutics placement
Apr 2026 Obsidian Therapeutics –Galera TherapeuticsMergerLegal adviser to Obsidian TherapeuticsCompleted413.5Biotech+2Galera Therapeutics and Obsidian Therapeutics merger

Deals where Tevia Pollard is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.